EuroPCR
May 21-24, 2013
Paris, France
VPM 2013
June 22-26, 2013
Paris, France
ESIR Tumour Ablation
November,8-9, 2013
Lausanne, Switzerland
NOBORI 2 Registry
Nobori® drug eluting stent shows superior safety and efficacy in bifurcation and diabetic patients
New Eliminate™ Aspiration Catheter
Removes life-threatening blockage in record time
Terumo Europe’s Interventional Cardiology division is a global leader in cardiovascular care, providing less invasive devices for the treatment of coronary artery disease.
Our philosophy is to deliver high quality devices with unique and innovative technology.
We offer a comprehensive device portfolio including products for the diagnosis and treatment of coronary artery disease.
| Drug Eluting Stent | Bare Metal Stent |
|---|---|
| PTCA Guiding Catheter | PTCA Guide Wire | PTCA Balloon Catheter | Aspiration Catheter | Micro-Guide Catheter |
|---|---|---|---|---|
| Introducer Sheath | Angiographic Catheter | Compression Device | Accessories |
|---|---|---|---|
| Console | Catheter |
|---|---|
| Console & Catheter |
|---|
August 30, 2010
Terumo is proud to participate in the Stent for Life Initiative
August 17, 2010
Terumo Corporation and Asahi Intecc announced to co-develop guide wires
March 23, 2009
Terumo completes enrolment of 3000 patients in NOBORI 2 – a Nobori® Drug Eluting Stent Trial